期刊文献+

热休克蛋白B1在胰腺癌组织中的表达及临床意义

Detection of HSPB1 expression in pancreatic cancer and its clinical significance
原文传递
导出
摘要 目的检测热休克蛋白B1(HSPB1)在胰腺癌组织中的表达,分析其与肿瘤临床病理特征间的关系。方法选取47例胰腺癌、13例癌旁组织、3例慢性胰腺炎组织标本,用组织芯片构建仪制备组织芯片,应用免疫组织化学sP法检测HSPB1的表达。以阳性细胞所占的比例和染色强度两者评分乘积为标准进行结果判断。结果胰腺癌、癌旁和慢性胰腺炎组织中HSPB1的阳性表达率分别为80.9%(38/47)、12.5%(2/16),两者差异具有统计学意义(X。=24.058,P=0.000)。胰腺癌组织HSPB1的表达与患者性别、年龄及肿瘤部位、组织学类型、神经浸润均无关(P值均〉0.05)。结论HSPB1参与了胰腺癌的发生、发展,这一过程可能是早期的分子事件。 Objective To investigate the expression of HSPB1 in pancreatic cancer and its relationship with clinicopathological characterization. Methods Pathological specimens from 47 cases of pancreatic cancers, 13 cases of para-cancerous normal pancreatic tissues and 3 cases of chronic pancreatitis tissues were selected, and tissue microarray construction instrument was used to prepare tissue microarray, then the expression of HSPB1 was determined by immunohistochemistry SP method. The scores of the proportion of positive cells and staining intensity were multiplied to make the judgment. Results The expression of HSPB1 in malignant, para-cancerous and chronic pancreatitis tissues was 80.9% ( 38/47 ), 12.5% ( 2/16 ), respectively; and the difference between the two groups was statistically significant (X2 =24.058, P =0.000). The expression of HSPB1 in pancreatic cancer tissue was not significantly related to sex, age, location, differentiation degree and nerve infiltration of tumor (P 〉 0.05 ). Conclusions The expression of HSPB1 is related to development and progression of pancreatic cancer, and may be an early molecular event.
出处 《中华胰腺病杂志》 CAS 2012年第3期170-172,共3页 Chinese Journal of Pancreatology
基金 国家自然科学基金(30770996,81172310)
关键词 胰腺肿瘤 热休克蛋白质类 芯片分析技术 免疫组织化学 Pancreatic neoplasm Heat-shock proteins Microchip analytical procedures Immunohistoche mistry
  • 相关文献

参考文献9

  • 1Kononen J,Bubendorf L,Kallioriemi A. Tissue microarrays for high-throughput molecular profiling of tumor specimens[J].Nature Medicine,1998.844-847.doi:10.1038/nm0798-844.
  • 2Ohuchida K,Mizumoto K,Ishikawa N. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic taget[J].Clinical Cancer Research,2005.7785-7793.
  • 3Arrigo AP. Hsp27:novel regulator of intracellular redox state[J].IUBMB Life,2001.303-307.
  • 4Berri~eman HK,Smith L,Lind MJ. Hsp27 may allow prediction of the response to single-agent vinorelbine chemotherapy in non-small cell lung cancer[J].Oncology Reports,2006.283-286.
  • 5Yang YX,Li JL,Zhu G. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SG C7901/VCR[J].Proteomics,2006.2009-2021.
  • 6Ciocca DR,Vargas-Roig LM. Hsp27 as a prognostic and predictive factor in cancer[J].Progress in Molecular and Subcellular Biology,2002.205-218.
  • 7Leonardi R,Pannone G,Magro G. Differential expression of heat shock protein 27 in normal oral mucosa,oral epithelial dysplasia and squamous cell carcinoma[J].Oncology Reports,2002.261-266.
  • 8Melle C,Ernst G,Escher N. Protein profiling of microdessected pancreas carcinoma and identification of HSP27 as a potential serum marker[J].Clinical Chemistry,2007.629-635.
  • 9BüngerS,Laubert T,Roblick UJ. Serum biomarkers for improved diagnostic of pancreatic cancer:a current overview[J].Journal of Cancer Research and Clinical Oncology,2011.375-389.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部